Angiogenesis, Exudation and Degeneration Meeting
Healio brings you the highlights from Angiogenesis, Exudation, and Degeneration. Refer back to this page often for the latest news from the meeting, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.
expand
SPONSORED CONTENT
February 24, 2021
1 min read
Save
NGM621 for geographic atrophy well tolerated in phase 1 study
Results from a phase 1 first-in-human study evaluating NGM621, an anti-complement C3 antibody, in geographic atrophy secondary to age-related macular degeneration showed the therapy was safe and well tolerated.
SPONSORED CONTENT
February 22, 2021
2 min watch
Save
VIDEO: Dugel discusses study results for Zimura in geographic atrophy
In this video, Pravin U. Dugel, MD, discusses phase 3 results of the GATHER1 study of Zimura (avacincaptad pegol, Iveric bio) for geographic atrophy in dry AMD, presented at the virtual Angiogenesis, Exudation, and Degeneration meeting.